Stephens Investment Management Group LLC Raises Stake in Simulations Plus, Inc. $SLP

Stephens Investment Management Group LLC lifted its stake in shares of Simulations Plus, Inc. (NASDAQ:SLP) by 30.8% during the fourth quarter, HoldingsChannel.com reports. The firm owned 513,728 shares of the technology company’s stock after purchasing an additional 120,888 shares during the period. Stephens Investment Management Group LLC’s holdings in Simulations Plus were worth $9,365,000 at the end of the most recent reporting period.

A number of other large investors have also made changes to their positions in SLP. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in Simulations Plus by 4.3% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 9,493 shares of the technology company’s stock worth $233,000 after buying an additional 390 shares in the last quarter. Prudential Financial Inc. grew its position in Simulations Plus by 5.7% during the second quarter. Prudential Financial Inc. now owns 17,213 shares of the technology company’s stock worth $300,000 after buying an additional 930 shares during the period. Invesco Ltd. increased its holdings in Simulations Plus by 3.8% in the second quarter. Invesco Ltd. now owns 36,452 shares of the technology company’s stock valued at $636,000 after buying an additional 1,323 shares in the last quarter. Raymond James Financial Inc. purchased a new position in Simulations Plus in the second quarter valued at about $25,000. Finally, US Bancorp DE boosted its stake in shares of Simulations Plus by 32.5% during the 3rd quarter. US Bancorp DE now owns 6,167 shares of the technology company’s stock worth $93,000 after acquiring an additional 1,513 shares in the last quarter. Hedge funds and other institutional investors own 78.08% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on SLP. TD Cowen dropped their price objective on Simulations Plus from $19.00 to $16.00 and set a “hold” rating for the company in a research note on Friday, April 10th. Zacks Research cut shares of Simulations Plus from a “strong-buy” rating to a “hold” rating in a research note on Monday, February 2nd. Finally, Wall Street Zen raised Simulations Plus from a “hold” rating to a “buy” rating in a report on Saturday. Three investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $24.40.

Simulations Plus Stock Performance

SLP stock opened at $13.34 on Monday. Simulations Plus, Inc. has a one year low of $11.09 and a one year high of $34.01. The stock has a market capitalization of $269.47 million, a P/E ratio of -4.26 and a beta of 1.28. The company has a 50 day moving average price of $13.23 and a two-hundred day moving average price of $15.75.

Simulations Plus (NASDAQ:SLP) last posted its quarterly earnings data on Thursday, April 9th. The technology company reported $0.35 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.27 by $0.08. The business had revenue of $24.29 million for the quarter, compared to analysts’ expectations of $21.66 million. Simulations Plus had a positive return on equity of 16.21% and a negative net margin of 77.96%. Research analysts forecast that Simulations Plus, Inc. will post 0.85 earnings per share for the current fiscal year.

Simulations Plus Company Profile

Simulations Plus, Inc (NASDAQ: SLP) specializes in advanced modeling and simulation software tailored to the pharmaceutical, biotechnology and chemical industries. The company’s flagship products include ADMET Predictor, a quantitative structure-activity relationship (QSAR) tool for predicting absorption, distribution, metabolism, excretion and toxicity properties, and GastroPlus, a physiologically based pharmacokinetic (PBPK) modeling platform for simulating drug absorption and pharmacokinetics.